The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults

IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy

NCT06013761 ·Status: COMPLETED ·Phase: NA

Ketogenic Diet in Pediatric Intractable Epilepsy

NCT06310954 ·Status: RECRUITING ·Phase: NA

A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy

NCT03999827 ·Status: COMPLETED ·Phase: NA

Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.

NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy

NCT01899898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy

NCT04311242 ·Status: WITHDRAWN

Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures

NCT05219006 ·Status: COMPLETED ·Phase: NA

Epigenetics and Gut Microbiota in Children With Epilepsy

NCT04063007 ·Status: UNKNOWN ·Phase: NA

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

NCT03059329 ·Status: COMPLETED

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00567424 ·Status: WITHDRAWN ·Phase: PHASE2

Energy Expenditure and Quality of Life in Epilepsy

NCT04546711 ·Status: WITHDRAWN

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

NCT00235755 ·Status: COMPLETED ·Phase: PHASE3

Comparison Between Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet

NCT03464487 ·Status: UNKNOWN ·Phase: NA

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

NCT02736162 ·Status: COMPLETED

An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data

NCT05632978 ·Status: RECRUITING

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

NCT00887861 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Evaluation of Ketoflo

NCT04399954 ·Status: COMPLETED ·Phase: NA

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

NCT06716801 ·Status: RECRUITING

A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

NCT04202159 ·Status: COMPLETED

Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues

NCT02565966 ·Status: COMPLETED ·Phase: NA

Use of Betashot in Children and Adults With Epilepsy

NCT02825745 ·Status: COMPLETED ·Phase: NA

Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT04879433 ·Status: UNKNOWN